Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Patterson-UTI Energy Inc. Common Stock (PTEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Patterson-UTI Energy Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Patterson-UTI Energy Inc. Common Stock trades at $11.6 (market cap $4.39B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 2× Patterson-UTI Energy Inc. Common Stock's market cap, and Patterson-UTI Energy Inc. Common Stock pays a 3.48% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Patterson-UTI Energy Inc. Common Stock for 3 Days on average.
| KYMR | PTEN | |
|---|---|---|
Market Cap | $8.87B | $4.39B |
Volume | 779,107 | 4,811,496 |
Sector | Health | Energy |
52-Week High | $127.31 | $13.15 |
52-Week Low | $55.80 | $5.41 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $8.26B | $5.47B |
Dividend Yield | — | 3.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Patterson-UTI Energy (PTEN) trades at $11.52, up 1.68% today, with a neutral technical signal. The stock shows strong cash flow from operations at $961.22M for 2025, but net income remains negative at -$93.64M. Recent earnings beats and an upcoming Q3 2026 report on October 29, 2026, highlight operational momentum, supported by an average of 103 drilling rigs in September 2026. Analyst consensus is bullish with a $13.38 price target, indicating a 16% upside.
The outlook is cautiously optimistic due to earnings consistency and positive analyst sentiment, but risks include persistent net losses, exposure to oil price volatility, and competitive pressures. Upside potential hinges on sustained rig demand and profitability improvements, while downside risks stem from macroeconomic headwinds affecting energy sectors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Patterson-UTI Energy Inc. Common Stock
Patterson-UTI Energy provides drilling, completion, and other oilfield services for oil and gas producers in the United States.
Read more on PTEN →
